Table 4 Cost implication findings from various studies
From: A review on prescribing patterns of antihypertensive drugs
Author Name | Number of subjects involved | Mono-/combination therapy prescribed | Observation/Remarks |
|---|---|---|---|
Rachana et al. [30] | 300 prescriptions | Mono (48.94Â %), CCB | Costliest - Alpha-blocker |
Cost effective - Diuretic | |||
Amira and Okubadejo [31] | 225 black patients | CCB | Cost effective - Amiloride |
Rimoy [8] | 600 patients | Diuretics | Govt. shops drugs 5–6 times cheaper than private shops |
Fisher and Avorn [32] | 133,624 patients | Combination (CCB + ACEI) | Adherence to guidelines result in savings |
Osibogun and Okwor [33] | 147 prescriptions | Diuretics 79.6Â % | Co-morbid conditions had high cost prescriptions |